Anticancer effects of sandalwood (Santalum album)

Anticancer Research

Volumn 35, Issue 6, 2015, Pages 3137-3145

  Santha, Sreevidya ^a,b   Dwivedi, Chandradhar ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Angiogenesis; Apoptosis; Cancer; Carcinogenesis; Cell cycle; Review; Sandalwood; Santalol

Indexed keywords

ALPHA SANTALOL; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; UNCLASSIFIED DRUG; PLANT EXTRACT; VEGETABLE OIL;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; BREAST CANCER; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; NON MELANOMA SKIN CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SANTALUM ALBUM; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION; ANIMAL; CARCINOGENESIS; CELL CYCLE CHECKPOINT; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; MOUSE; SANTALUM; SKIN NEOPLASMS;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE CHECKPOINTS; HUMANS; MICE; PLANT EXTRACTS; PLANT OILS; SANTALUM; SKIN NEOPLASMS;

EID: 84931306088     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Amin A, Gali-Muhtasib H, Ocker M and Schneider-Stock R: Overview of Major Classes of Plant-Derived Anticancer Drugs. Int J Biomed Sci 5: 1-11, 2009.
2. Bar-Sela G, Epelbaum R and Schaffer M: Curcumin as an anticancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17: 190-197, 2010.
3. Dwivedi C and Abu-Ghazaleh A: Chemopreventive effects of sandalwood oil on skin papillomas in mice. Eur J Cancer Prev 6: 399-401, 1997.
4. Dwivedi C and Zhang Y: Sandalwood oil prevent skin tumour development in CD-1 mice. Eur J Cancer Prev 8: 449-455, 1999.
5. Dwivedi C, Guan X, Harmsen WL, Voss AL, Goetz-Parten DE, Koopman EM, Johnson, Valluri HB and Matthees DP: Chemopreventive effects of α-santalol on skin tumor development in CD-1 and SENCAR mice. Cancer Epidemiol Biomarkers Prev 12: 151-156, 2003.
6. Dwivedi C, Maydew ER, Hora JJ, Ramaekar DM and Guan X: Chemopreventive effects of various concentrations of α-santalol on skin cancer development in CD-1 mice. Eur J Cancer Prev 14: 473-476, 2005.
7. Kaur M, Agarwal C, Singh RP, Guan XM, Dwivedi C and Agarwal R: Skin cancer chemopreventive agent, alpha-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis 26: 369-380, 2005.
8. Dwivedi C, Valluri HB, Guan X and Agarwal R: Chemopreventive effects of α-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. Carcinogenesis 27: 1917-1922, 2006.
9. Bommareddy A, Hora J, Cornish and Dwivedi C: Chemoprevention by alpha-santalol on UV B radiation-induced skin tumor development in mice. Anticancer Res 27: 2185 2188, 2007.
10. Arasada BL, Bommareddy A, Zhang X, Bremmon K and Dwivedi C: Effect of alpha-santalol on proapoptotic caspases and p53 expression in UVB-irradiated mouse skin. Anticancer Res 28: 129-132, 2008.
11. 2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells. BMC Res Notes 3: 220, 2010.
12. Bommareddy A, Rule B, VanWert AL, Santha S and Dwivedi C: α-Santalol, a derivative of sandalwood oil, induces apoptosis in human prostate cancer cells by causing caspase-3 activation. Phytomedicine 19: 804-811, 2012.
13. 2/M phase and induction of apoptosis. PLoS ONE 8: e56982, 2013.
14. Santha S and Dwivedi C: α-santalol, a skin cancer chemopreventive agent with potential to target various pathways involved in photocarcinogenesis. Photochem Photobiol 89: 919-926, 2013.
15. Burdock GA and Carabin G: Safety assessment of sandalwood oil (Santalum album L.). Food Chem Toxicol 46: 421-432, 2008.
16. Kumar ANA, Joshi G and Ram HYM: Sandalwood: history, uses, present status and the future. Current Science 103: 1408-1416, 2012.
17. Fox JE: Sandalwood: the royal tree. Biologist 47: 31-34, 2000.
18. Baldovini N, Delasalle C and Joulain D: Phytochemistry of the heartwood from fragrant Santalum species: a review. Flavour Frag J 26: 7-26, 2011.
19. Misra BB and Dey S: Comparative phytochemical analysis and antibacterial efficacy of in vitro and in vivo extracts from East Indian sandalwood tree (Santalum album L.). Lett Appl Microbiol 55: 476-486, 2012.
20. Hasegawa T, Izumi H, Tajima Y and Yamada H: Structure-odor relationships of α-santalol derivatives with modified side chains. molecules 17: 2259-2270, 2012.
21. Nikiforov A, Jirovetz L, Buchbauer G and Raverdino V: GC-FTIR and GC-MS in odour analysis of essential oils. Mikrochim Acta 11: 193-198, 1988.
22. Howes MJ, Simmonds MS and Kite GC: Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry. J Chromatogr A 1028: 307-312, 2004.
23. Subasinghe U, Gamage M and Hettiarachchi DS: Essential oil content and composition of Indian sandalwood (Santalum album) in Sri Lanka. J Forest Res 24: 127-130, 2013.
24. Misra BB and Dey S: Biological activities of East Indian sandalwood tree, Santalum album. Peer J Pre Prints 96v1, 2013.
25. Chopra RN, Chopra IC and Verma BS: Supplement to Glossary of Indian Medicinal Plants. Publication and Information Directorate (CSIR), New Delhi, 1969.
26. Kapoor LD: (ed.). Handbook of Ayurvedic Medicinal Plants, p. 297. BocaRaton, FL: CRC Press, 1990.
27. Boutwell RK: Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 4: 207-250, 1984.
28. Ahmad N, Khan MSA, Jais AMM, Mohtaruddin N, Ranjbar M, Amjad MS, Nagaraju B, Faraz M, Pathan F and Chincholi AA: Anti-ulcer activity of sandalwood (Santalum album L.) stem hydroalcoholic extract in three gastric-ulceration models of Wistar rats. Bol Latinoam Caribe Plant Med Aromat 12: 81-91, 2013.
29. Kausar H, Jahan N, Ahmed K, Aslam M, Ahmed P and Ahmed S: Unani perspective and recent studies of sandal safed (Santalum album Linn.): a review: World J Pharm Pharmaceut Sci 3: 2133-2145, 2014.
30. Setzer WN: Essential oils and anxiolytic aromatherapy. Nat Prod Commun 4: 1305-1316 2009.
31. Ohmori A, Shinomiya K, Utsu Y, Tokunaga S, Hasegawa Y and Kamei C: Effect of santalol on the sleep-wake cycle in sleepdisturbed rats. Nihon Shinkei Seishin Yakurigaku Zasshi 27: 167-171, 2007.
32. Kyle G: Evaluating the effectiveness of aromatherapy in reducing levels of anxiety in palliative care patients: results of a pilot study. Complement Ther Clin Pract 12: 148-155, 2006.
33. Kumar MG, Jeyraaj IA, Jeyaraaj R and Loganathan P: Antimicrobial activity of aqueous extract of leaf and stem extract of Santalum album. Anc Sci Life 25: 6-9, 2006.
34. Shamsi TN, Parveen R, Afreen S, Azam M, Fatma T, Haque QMR and Fatima S: In-vitro antibacterial and antioxidant activities of sandalwood (Santalum album). Austin J Biotechnol Bioeng 1: 3, 2014,
35. Benencia F and Courreges MC: Antiviral activity of sandalwood oil against herpes simplex viruses-1 and 2. Phytomedicine 6: 119-123, 1999.
36. Kelloff GJ, Boone CW, Steele VE, Fay JR, Lubet RA, Crowell JA and Sigman CC: Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 20: 1-24, 1994.
37. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M and Diederich M: Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190, 2005.
38. Banerjee S, Ecavade A and Rao AR: Modulatory influence of sandalwood oil on mouse hepatic glutathione-S-transferase activity and acid soluble sulfhydryl level. Cancer Lett 68: 105-109, 1993.
39. Townsend DM and Tew KD: The role of glutathione-Stransferase in anticancer drug resistance. Oncogene 22: 7369-7375, 2003.
40. Dickinson SE, Olson ER, Levenson C, Janda J, Rusche JJ, Alberts DS and Bowdenet GT: A novel chemopreventive mechanism for a traditional medicine: East Indian sandalwood oil induces autophagy and cell death in proliferating keratinocytes. Arch Biochem Biophys 558: 143-152, 2014.
41. Li X, Xu HL, Liu YX, An N, Zhao S and Bao JK: Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacol Sin 34: 612-624, 2013.
42. Dozmorov MG, Yang Q, Wu W, Wren J, Suhail MM, Woolley CL, Young DG, Fung K and Lin H: Differential effects of selective frankincense (Ru Xiang) essential oil versus nonselective sandalwood (Tan Xiang) essential oil on cultured bladder cancer cells: a microarray and bioinformatics study. Chin Med 9: 18, 2014.
43. Matsuo Y and Mimaki Y: Lignans from Santalum album and their cytotoxic activities. Chem Pharm. Bull 58: 587-590, 2010.
44. Zhang X and Dwivedi C: Skin cancer chemoprevention by α-santalol. Front Biosci 3: 777-787, 2011.
45. Saraswati S, Kumar S and Alhaider AA: α-Santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. Mol Cancer 12: 147, 2013.
46. Matsuo Y and Mimaki Y: α-Santalol derivatives from Santalum album and their cytotoxic activities. Phytochemistry 77: 304-311, 2012.
47. Vermeulen K, Van Bockstaele DR and Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003.
48. Park MT and Lee S: Cell Cycle and Cancer. J Biochem Mol Biol 36: 60-65, 2003.
49. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
50. Mueller PR, Coleman TR, Kumagai A and Dunphy WG: Myt1: a membrane associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270: 86-90, 1995.
51. Gautier J, Solomon MJ, Booher RN, Bazan JF and Kirschner MW: Cdc25 is a specific tyrosine phosphatase that directly activates p34Cdc2. Cell 67: 197-211, 1991.
52. 2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279: 25813-25822, 2004.
53. Slee EA, Adrain C and Martin SJ: Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276: 7320-7326, 2001.
54. Moy RL, Levenson C, So JJ and Rock J: Single-center, open label study of a proprietary topical 0.5% salicylic acid-based treatment regimen containing sandalwood oil in adolescents and adult with mild to moderate acne. J Drugs Dermatol 11: 1403-1408, 2012.
55. Palatty PL, Azmidah A, Rao S, Jayachander D, Thilakchand KR, Rai MP, Haniadka R, Simon P, Ravi R, Jimmy R, D'souza PF, Fayad R, and Baliga M S: Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol 87(1038): 20130490, 2014.
56. Li G, Singh A, Liu Y, Sunderland B and Li D: Comparative effects of sandalwood seed oil on fatty acid profiles and inflammatory factors in rats. Lipids 48: 105-113, 2013.
57. Sharma M, Levenson C, Bell RH, Anderson SA, Hudson JB, Collins CC and Cox ME: Suppression of lipopolysaccharidestimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol. Phytother Res 28: 925-932, 2014.
58. Baylac S and Racine P: Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromather 3: 138-142, 2003.
59. Scartezzini P and Speroni E: Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71: 23-44, 2000.
60. Misra BB and Dey S: Evaluation of in vivo anti-hyperglycemic and antioxidant potentials of α-santalol and sandalwood oil. Phytomedicine 20: 409-416, 2013.
61. Saraswati S, Kanaujia PK and Agrawal SS: α-Santalol demonstrates antitumor and antiantiangiogenic activities in models of hepatocellular carcinoma in vitro and in vivo. Dig Liver Dis 45S: S233-S260, 2013.